Anti-fibroblast growth factor-8 monoclonal antibody

Details Anti-fibroblast growth factor-8 monoclonal antibody Anti-fibroblast growth factor-8 monoclonal antibody

2007-07-10

2007-07-10

Foley, Shanon (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C424S130100, C424S142100, C424S155100

Reexamination Certificate

active

10434469

ABSTRACT:
A method for preventing or treating a disease, comprising administering to human or animal in need of such prevention or treatment an effective amount of a monoclonal antibody which specifically binds to FGF-8 and inhibits FGF-8 activity.

REFERENCES:
patent: 5225539 (1993-07-01), Winter
patent: 5585089 (1996-12-01), Queen et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5952472 (1999-09-01), Hanai et al.
patent: 6180370 (2001-01-01), Queen et al.
patent: 6310184 (2001-10-01), Hanai et al.
patent: 6331415 (2001-12-01), Cabilly et al.
patent: 0 799 835 (1997-10-01), None
patent: 0799835 (1997-10-01), None
patent: 0 882 794 (1998-12-01), None
patent: 1 422 243 (2004-05-01), None
patent: 1422243 (2004-05-01), None
patent: 2001-46066 (2001-02-01), None
patent: WO 92/12734 (1992-08-01), None
patent: 9503831 (1995-02-01), None
patent: WO 03/002608 (2003-01-01), None
patent: WO 2003002608 (2003-01-01), None
Dorin et al. (Oncogene 1999; 18: 2755-2761).
Valve et al. (In. J. Cancer 2000, 88: 718-725).
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4.
Dermer (Bio/Technology, 1994, 12:320).
Johnstone and Thorpe (Immunochemistry in Practice, Blackwell Scientific Publications, Oxford), 1987.
Kimmel et al (J. Neurosurg., 66:161-171), 1987.
Hird et al (Genes and Cancer, Carney et al., Ed., John Wiley and Sons, Ltd), 1990.
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., New York), 1983.
Jain (Scientific American Jul. 1994).
Gura (Science, v278, 1997, pp. 1041-1042).
Dermer (Bio/Technology, 12:320), 1994.
Gura (Science, 278:1041-1042), 1997.
Jain (Sci. Am., 271:58-65), 1994.
Curti (Crit. Rev. in Oncology/Hermatology, 14:29-39), 1993.
Hartwell et al (Science, 278:1064-1068), 1997.
Sato et al (J. Steroid Biochem. Molec. Bio., 1993, 47 [1-6] 91-98).
Koga et al(J. Steroid Biochem. Molec. Biol., 1995, 54 [½] 1-6).
Sevier et al (Clin. Chem., 1981, 27(11) 1797-1806).
Dermer (Bio/Technology, 12:230).
Gura (Science, 278:1041-1042).
Jain (Sci. Am., 271:58-65).
Curti (Crit. Rev. in Oncology/Hamatology, 14:29-39).
Johnstone and Thorpe (Immunochemistry in Practice, Blackwell Scientific Publications, Oxford) 1987.
Kimmel et al (J. Neurosurg., 66: 161-171) 1987.
Hird et al (Genes and Cancer, Carney et al., Ed., John Wiley and Sons, Ltd.) 1990 O:\bjs\249\249-310\7.pdf.
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., NY) 1983.
Prac. Natl. Acad. Sci. USA, vol. 89, pp. 8928-8932, Oct. 1992, Biochemistry, Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells, Tanaka et al.
FEBS LETTERS 3663 (1995) 226-230, Federation of European Biochemical Societies, “Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties” Tanaka et al.
MacArthur et al 1995 Cell Growth and Differentiation, vol. 6, pp. 817-825 FGF-8 Isoforms Differ in NIH3T3.
Roitt Essential IMmunoloogy 6thEdition Production of Effectors pp. 107-109 The monoclonal antibody revolution.
Lorenzi et al, “Expression Cloning Development . . . ”, Oncogene vol. 10 No. 10, 1995, pp. 2051-2055.
Tanaka et al, “High Frequency of Fibroblast Growth Factor . . . ”, Cancer Research vol. 58, No. 10, May 1998, pp. 2053-2056.
Sato et al. J Steroid Biochem Molec. Bio, 1993, 47 (1-6) 91-98.
Koga et al. J Steroid Biochem Molec. Bio, 1995, 54 (½) 1-6.
Seiver et al (Clin Chem 1981, 27(11) 1797-1806).
Yoshida et al (Agro Biol Chem 53(4) 1095-1101 (1989).
Lorenzi et al, “Expression Cloning Development . . . ”, Oncogene vol. 10 No. 10, 1995, pp. 2051-2055.
Tanaka et al, “High Frequency of Fibroblast Growth Factor . . . ”, Cancer Research vol. 58, No. 10, May 1998, pp. 2053-2056.
Prac. Natl. Acad. Sci. USA, vol. 89, pp. 8928-8932, Oct. 1992, Biochemistry, “Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells”, Tanaka et al.
FEBS LETTERS 3663 (1995) 226-230, Federation of European Biochemical Societies, “Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties”, Tanaka et al.
MacArthur et al 1995 Cell Growth and Differentiation, vol. 6 pp. 817-825 FGF-8 Isoforms Differ in NIH3T3.
Roitt Essential Immunology 6thEdition Production of Effectors pp. 107-109 The Monoclonal antibody revolution.
VJ Gnanapragasam et al, British Journal of Cancer, 2003, 88, pp. 1432-1438.
Morrison et al, Proc. Natl. Acad. Sci., Nov. 1984, vol. 81, pp. 6851-6855.
Jones et al, Nature, vol. 321, May 29, 1986, pp. 522-525.
Reichmann et al, Nature, vol. 332, Mar. 24, 1988, pp. 323-327.
Lorenzi et al, Oncogene (1995), vol. 10, pp. 2051-2055.
Tanaka et al, Cancer Research, 1998, vol. 58, No. 10, pp. 2053-2056.
Vaughan et al, 1998, vol. 16, No. 6, pp. 535-539.
Supplementary European Search Report dated Mar. 23, 2005 issued in EP 02 74 3765.

Affiliated with

Also associated with

Rating

Anti-fibroblast growth factor-8 monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-fibroblast growth factor-8 monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-fibroblast growth factor-8 monoclonal antibody will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3723331